Results
|
1.
|
|
|
2.
|
|
|
3.
|
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients. [electronic resource] by
- Scartozzi, M
- Giampieri, R
- Maccaroni, E
- Del Prete, M
- Faloppi, L
- Bianconi, M
- Galizia, E
- Loretelli, C
- Belvederesi, L
- Bittoni, A
- Cascinu, S
Producer: 20120418
In:
British journal of cancer vol. 106
Availability: No items available.
|
|
4.
|
Epidermal growth factor receptor (EGFR) gene promoter methylation and cetuximab treatment in colorectal cancer patients. [electronic resource] by
- Scartozzi, M
- Bearzi, I
- Mandolesi, A
- Giampieri, R
- Faloppi, L
- Galizia, E
- Loupakis, F
- Zaniboni, A
- Zorzi, F
- Biscotti, T
- Labianca, R
- Falcone, A
- Cascinu, S
Producer: 20110721
In:
British journal of cancer vol. 104
Availability: No items available.
|
|
5.
|
Increased rates of local complication of central venous catheters in the targeted anticancer therapy era: a 2-year retrospective analysis. [electronic resource] by
- Berardi, R
- Rinaldi, S
- Santini, D
- Vincenzi, B
- Giampieri, R
- Maccaroni, E
- Marcucci, F
- Francoletti, M
- Onofri, A
- Lucarelli, A
- Pierantoni, C
- Tonini, G
- Cascinu, S
Producer: 20150617
In:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer vol. 23
Availability: No items available.
|
|
6.
|
Analysis of HER-3, insulin growth factor-1, nuclear factor-kB and epidermal growth factor receptor gene copy number in the prediction of clinical outcome for K-RAS wild-type colorectal cancer patients receiving irinotecan-cetuximab. [electronic resource] by
- Scartozzi, M
- Giampieri, R
- Maccaroni, E
- Mandolesi, A
- Giustini, L
- Silva, R
- Zaniboni, A
- Biscotti, T
- Biagetti, S
- Galizia, E
- Loupakis, F
- Falcone, A
- Bearzi, I
- Cascinu, S
Producer: 20121022
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 23
Availability: No items available.
|
|
7.
|
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib. [electronic resource] by
- Scartozzi, M
- Bianconi, M
- Faloppi, L
- Loretelli, C
- Bittoni, A
- Del Prete, M
- Giampieri, R
- Maccaroni, E
- Nicoletti, S
- Burattini, L
- Minardi, D
- Muzzonigro, G
- Montironi, R
- Cascinu, S
Producer: 20130521
In:
British journal of cancer vol. 108
Availability: No items available.
|